Working as a Team for Improved Patient Outcomes in Type 2 Diabetes

Slides:

Advertisements

Similar presentations

Apr-15 Insulin Pump Therapy – A Shared Journey Heather Maxwell Diabetes Specialist Nurse Insulin Pump Service Greater Glasgow & Clyde.

Advertisements

Diabetes Self Management Education & Teaching(DSME/T): A Study Guide for Pharmacists Katherine Werner, PharmD, CDE, CACP, CGP.

Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized,

Improving Patient Outcomes in Diabetes Matt Petersen Managing Director, Medical Information & Professional Engagement American Diabetes Association.

What's New in Basal Insulin for Diabetes

Fig. 1. Study flow chart. Group A: intensifying oral hypoglycemic agents (OHAs; sulfonylurea+metformin dose titration or fixed-dose combination added to.

Case-Based Examination of Treatment Options in Type 2 Diabetes Management.

Copyright © 2015 by the American Osteopathic Association.

A Case-Based Inside Workshop”

Virtual Nursing Care for School Children with Diabetes

Diabetic Dyslipidemia in Practice

Updates and Perspectives in Diabetic Dyslipidemia

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Applying Data to Practice

Special Consideration in Insulin Therapy

SGLT2 Inhibitors: What Do the Data Mean for My Patients?

New Patient-Friendly Options for Managing Insulin Dosing

Modern Strategies for Basal Insulin Use in T2D

Patient Case Discussions in T2D: What Intensification Plan Is Best?

Insulin/GLP-1 Agonist Combinations

Updates on Outcomes for Novel T2D Therapies

Obesity and Dyslipidemia: How Would You Treat?

Program Goals. Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin.

Insulin Intensification Strategies in Later-Stage Type 2 Diabetes Mellitus.

How Early Should Basal Insulin Be Used in T2D Management?

Updates Abound.

Antihyperglycemic therapy in type 2 diabetes: general recommendations.

Examining CV Effects of Basal Insulin Therapy

Updates to Managing Diabetes in the Long-Term Care Setting

What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?

Innovative Insulin Combinations: A New strategy for the Person With T2DM.

Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.

How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?

Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?

GLP-1 Receptor Agonists: How Early Is Appropriate?

Goals. The Truth About Statins: High vs Moderate Dose for Secondary Prevention of CAD.

Talking to Patients About Diabetes Management

Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?

A Journal Club on Lipid Management:

2008 FDA Guidance. Working as a Team for Cardiovascular Risk Reduction in Patients With T2D.

Early and Intensive T2D Management:

Insulin/GLP-1 Agonist Combinations

Insulin Use in Primary Care: Practice Challenges

Injectable Options as Add-Ons to Basal Insulin: Targeting PPG in Type 2 Diabetes Patients.

New Horizons in Adjunctive Type 1 Diabetes Management With SGLT Inhibitors.

Average patient profile in terms of (A) previous therapy drug class and (B) complexity of previous regimen. Average patient profile in terms of (A) previous.

T2DM, CV Safety, and Efficacy: DPP-4 Inhibitors in focus

LEADER One Year On.

Antihyperglycemic Therapy

Antihyperglycemic therapy in type 2 diabetes: general recommendations.

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

Program. Basal Insulin in the Modern Era The CDE's Role in Improving Utilization and Outcomes.

Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.

Statins, Obesity, and Hyperlipidemia

COMBINATIONS AND COFORMULATIONS: THE FUTURE OF INSULIN THERAPY?

Liraglutide Shows CV Benefit: Clinical Perspectives on the LEADER Trial

Patient Selection for Modern T2D Agents

Goals. The Truth About Statins: High vs Moderate Dose for Secondary Prevention of CAD.

Improving Effective Basal Insulin Use in Clinical Practice

Respondents’ perceptions on (A) the potential of IDegLira compared with basal-bolus therapy to improve patient motivation to reach their target blood glucose.

Strengthening Lung Cancer Team Connections to Improve Outcomes With Immunotherapy.

Getting PPG Under Control

Emerging Combination Injectable Therapy A New Era in Diabetes Care

What's New in Oral Combination Therapy for Type 2 Diabetes?

Practical Strategies for Overcoming Emotional Barriers to Insulin Initiation in the Primary Care Setting.

Fixed-Ratio Combination Therapy in T2DM

Examining the Role of Pharmacokinetics in Hemophilia

Guideline approach to drug therapy in newly diagnosed type 2 diabetic patients not at target. Guideline approach to drug therapy in newly diagnosed type.

Fresh perspectives ON BASAL Insulins in diabetes care

What Do the Guidelines Say About The Role of the HF Nurse?

Presentation transcript:

Working as a Team for Improved Patient Outcomes in Type 2 Diabetes

T2D Characterized by β-Cell Failure

Successfully Starting an Injectable

Finding the Right Insulin Dose for Your Patient

Intensifying Basal Insulin Therapy With a GLP-1 RA: 2017 ADA Guidelines

Combination of Basal Insulin With a GLP-1 RA in the Same Syringe

Fixed Combination Injectable GLP-1 RA/Basal Insulin Combinations

Starting a GLP-1 RA/Basal Insulin Combination

AEs of GLP-1 RA/Basal Insulin Combinations

Administering the GLP-1 RA/Basal Insulin Combinations

DSME/S

GLP-1 RAs "Fix" 6 of the 8 Defects

Who Is on the "Team" and What Is Their Role?

The Endocrinologist's Role in Optimizing Diabetes Care

The Pharmacist's Role in Optimizing Diabetes Care

The Nurse's Role in Optimizing Diabetes Care

The Primary Care Provider’s Role in Optimizing Diabetes Care

In Whom to Use the GLP-1 RA/Basal Insulin Combinations?

Insulin "Fixes" 5 of the 8 Defects

A Closer Look at iGlarLixi

A Closer Look at iDegLira

How to Effectively Use CDEs for Patient Education

What to Educate Patients on Regarding the GLP-1 RA/Basal Insulin Combinations

Abbreviations